A detailed history of Massmutual Trust CO Fsb transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 113 shares of RLMD stock, worth $42. This represents 0.0% of its overall portfolio holdings.

Number of Shares
113
Previous 113 -0.0%
Holding current value
$42
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 03, 2024

SELL
$2.45 - $4.22 $139 - $240
-57 Reduced 33.53%
113 $0
Q3 2023

Oct 03, 2023

SELL
$2.48 - $3.79 $1,520 - $2,323
-613 Reduced 78.29%
170 $0
Q2 2023

Aug 01, 2023

BUY
$2.22 - $3.54 $1,738 - $2,771
783 New
783 $1,000
Q3 2022

Oct 07, 2022

BUY
$18.3 - $37.02 $1,683 - $3,405
92 New
92 $3,000
Q1 2022

Apr 08, 2022

SELL
$16.72 - $26.99 $468 - $755
-28 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$16.93 - $26.82 $474 - $750
28 New
28 $1,000

Others Institutions Holding RLMD

About RELMADA THERAPEUTICS, INC.


  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $10.9M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.